Clinical Trials Browser

OTHER × sotigalimab × 30 days × Clear all

NCT04130854 2026-05-06

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

Phase 2 Completed

Gastrointestinal

Locally Advanced Rectal Adenocarcinoma